Cytyc To Begin Direct Sales Effort In Five Regional Markets On April 1
This article was originally published in The Gray Sheet
Executive Summary
Cytyc will assume responsibility for direct sales and marketing for the ThinPrep cervical cancer screening test in April following the expiration of its national marketing agreement with Bristol-Myers Squibb's Mead Johnson division, VP Corporate Operations Dan Levangie told investors Feb. 2 at the Piper Jaffray health care conference in New York City.